CLINICAL_TRIALS
trial_result
· 2022-04-22
Clinical Trial Update: Convalescent Plasma to Stem Coronavirus (CSSC-001) [Phase 2]
Summary
Phase 2 trial update on convalescent plasma for coronavirus treatment completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Coronavirus, Convalescence | Phase 2 | Status: COMPLETED | Results posted: 2022-04-22